Literature DB >> 17549440

[Necrolytic migratory erythema in glucagonoma syndrome].

I Stark1, C H Mensing, C A Sander.   

Abstract

The glucagonoma syndrome is a rare disease in which a typical skin lesion, necrolytic migratory erythema, is often one of the presenting symptoms. A 68-year-old woman developed erythematous polycyclic migratory lesions with advancing scaling borders and crusts over several years. Skin biopsies, laboratory studies and imaging confirmed the diagnosis of necrolytic migratory erythema as part of a glucagonoma syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17549440     DOI: 10.1007/s00105-007-1351-8

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  8 in total

Review 1.  Endocrine tumours of the pancreas.

Authors:  Kjell Oberg; Barbro Eriksson
Journal:  Best Pract Res Clin Gastroenterol       Date:  2005-10       Impact factor: 3.043

2.  Necrolytic migratory erythema with pancreatic carcinoma.

Authors:  D S Wilkinson
Journal:  Proc R Soc Med       Date:  1971-12

3.  Malignant glucagonoma. New options of treatment.

Authors:  M Appetecchia; E Ferretti; M Carducci; F Izzo; L Carpanese; F Marandino; E Terzoli
Journal:  J Exp Clin Cancer Res       Date:  2006-03

4.  Treatment of malignant endocrine pancreatic tumors with a combination of alpha-interferon and somatostatin analogs.

Authors:  M L Fjällskog; A Sundin; J E Westlin; K Oberg; E T Janson; B Eriksson
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

5.  Glucagonoma and pseudoglucagonoma syndrome.

Authors:  Miguel Echenique-Elizondo; Ana Tuneu Valls; José L Elorza Orúe; Ignacio Martinez de Lizarduy; Javier Ibáñez Aguirre
Journal:  JOP       Date:  2004-07

6.  Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors--the International Lanreotide and Interferon Alfa Study Group.

Authors:  Siegbert Faiss; Ulrich-Frank Pape; Michael Böhmig; Yvonne Dörffel; Ulrich Mansmann; Werner Golder; Ernst Otto Riecken; Bertram Wiedenmann
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544

7.  Necrolytic migratory erythema without glucagonoma in patients with liver disease.

Authors:  M P Marinkovich; R Botella; J Datloff; O P Sangueza
Journal:  J Am Acad Dermatol       Date:  1995-04       Impact factor: 11.527

8.  The glucagonoma syndrome. Clinical and pathologic features in 21 patients.

Authors:  R A Wermers; V Fatourechi; A G Wynne; L K Kvols; R V Lloyd
Journal:  Medicine (Baltimore)       Date:  1996-03       Impact factor: 1.889

  8 in total
  2 in total

1.  [67/f with erythematous scaly plaques expanding centrifugally on the abdomen : Preparation for the specialist examination: part 11].

Authors:  D Belz
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

Review 2.  [Paraneoplasms of the skin].

Authors:  C Gießen-Jung; A Wollenberg; M Reinholz
Journal:  Internist (Berl)       Date:  2018-02       Impact factor: 0.743

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.